Literature DB >> 21132573

A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management.

Andrew S Epstein1, Eileen M O'Reilly, Maeve Lowery, Ali Shamseddine, Jinru Shia, Sally Temraz, Ashwaq Al-Olayan, Mohamed Naghy, David Kelsen, Manish A Shah, Ghassan K Abou-Alfa.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21132573     DOI： 10.1007/s12029-010-9234-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  14 in total

1.  Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Authors:  Fidel-David Huitzil-Melendez; Marinela Capanu; Eileen M O'Reilly; Austin Duffy; Bolorsukh Gansukh; Leonard L Saltz; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.

Authors:  R E Wilentz; M Goggins; M Redston; V A Marcus; N V Adsay; T A Sohn; S S Kadkol; C J Yeo; M Choti; M Zahurak; K Johnson; M Tascilar; G J Offerhaus; R H Hruban; S E Kern
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.

Authors:  Ahsun Riaz; Frank H Miller; Laura M Kulik; Paul Nikolaidis; Vahid Yaghmai; Robert J Lewandowski; Mary F Mulcahy; Robert K Ryu; Kent T Sato; Ramona Gupta; Ed Wang; Talia Baker; Michael Abecassis; Al B Benson; Albert A Nemcek; Reed Omary; Riad Salem
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

Review 4.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Authors:  M Goggins; G J Offerhaus; W Hilgers; C A Griffin; M Shekher; D Tang; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

6.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Authors:  Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk Kim; Rongcheng Luo; Jifeng Feng; Shenglong Ye; Tsai-Sheng Yang; Jianming Xu; Yan Sun; Houjie Liang; Jiwei Liu; Jiejun Wang; Won Young Tak; Hongming Pan; Karin Burock; Jessie Zou; Dimitris Voliotis; Zhongzhen Guan
Journal:  Lancet Oncol       Date:  2008-12-16       Impact factor: 41.316

Review 7.  The use of imaging in the diagnosis and staging of hepatobiliary malignancies.

Authors:  George Miller; Lawrence H Schwartz; Michael D'Angelica
Journal:  Surg Oncol Clin N Am       Date:  2007-04       Impact factor: 3.495

Review 8.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.

Authors:  H T Lynch; P M Lynch; S J Lanspa; C L Snyder; J F Lynch; C R Boland
Journal:  Clin Genet       Date:  2009-07       Impact factor: 4.438

Review 9.  Toxicity of sorafenib: clinical and molecular aspects.

Authors:  Benoit Blanchet; Bertrand Billemont; Stéphane Barete; Hélène Garrigue; Laure Cabanes; Romain Coriat; Camille Francès; Bertrand Knebelmann; François Goldwasser
Journal:  Expert Opin Drug Saf       Date:  2010-03       Impact factor: 4.250

10.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.